Traitement des carcinoses péritonéales d'origine colo-rectale. Quoi ...

More documents

Recommendations

Info

Original Article Figure 4. Overall survival is illustrated according to the extent of institutional experience. Figure 5. Overall survival is illustrated according to the period when the procedure was performed. of cisplatin) and may have increased the rate of some surgical complications (fistula), most complications that we observed were caused by the surgery itself (digestive fistula, intraperitoneal hemorrhage, and abscesses). The extent of carcinomatosis also had a significant influence on survival and was correlated strongly with the completeness of cytoreduction (ie, the size of residual tumor nodules). For intraperitoneal chemotherapy to be effective, residual disease after attempted cytoreductive surgery must be of low volume. For <strong>colo</strong>rectal or gastric carcinomatosis, long-term survival was obtained only by patients who underwent complete macroscopic resection (CCR-0). Elias et al 13 recently reported a 5-year survival rate of >50% and a median survival of 63 months for Figure 6. Overall survival is illustrated according to the completeness of cytoreduction achieved. Table 7. Multivariate Analysis of Prognostic Factors for Overall Survival in 1290 Patients With Peritoneal Carcinomatosis of Digestive or Primary Origin Who Underwent Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy Variable RR 95% CI P Colorectal cancer 1.000 — — Pseudomyxoma peritonei 0.157 0.104-0.237
CCR-1 resection (residual tumor nodules
Page 1 and 2: SOMMAIRE Modérateurs : D. ELIAS (V
Page 3 and 4: The primary peritoneal malignancies
Page 5 and 6: Table 1. Origin of Carcinomatosis i
Page 7 and 8: Figure 3. Overall survival rates ar
Page 9: Table 6. Prognostic Impact of Clini
Page 13 and 14: QUOI DE NEUF DANS LA LITTERATURE SU
Page 15 and 16: Références 1. Elias D, Gilly F, B
Page 17 and 18: CHIMIOTHERAPIE INTRAPERITONEALE PER
Page 19 and 20: et/ou de réparer les dommages à l
Page 21 and 22: d’anthracycline comme la doxorubi
Page 23 and 24: Références 1. Benoit L, Cheynel N
Page 25 and 26: 25. Shah DK, Veith J, Bernacki RJ,
Page 27 and 28: péritonectomies sélectives, réal
Page 29 and 30: zones atteintes de maladie macrosco
Page 31 and 32: Une équipe grecque a proposé apr
Page 33 and 34: Il peut donc être utile, en cas de
Page 35 and 36: Le second look chirurgical a été
Page 37 and 38: a) patients présentant une carcino
Page 39 and 40: CHIP: LES ESSAIS THERAPEUTIQUES EN

Traitement des carcinoses péritonéales d'origine colo-rectale. Quoi ...

Create successful ePaper yourself

Delete template?

Save as template?